期刊文献+

糖尿病大鼠PAI-1 mRNA的表达与心肌微血管改变的相关性研究 被引量:1

PAI-1 mRNA expression and myocardial mircovascular change in diabetic rats
下载PDF
导出
摘要 目的通过研究老龄和青年糖尿病(DM)大鼠心肌微血管数目与心肌组织PAI-1 mRNA表达的改变,探讨高血糖和增龄对心肌微血管数目及心肌组织PAI-1 mRNA表达的影响。方法老龄和青年SD大鼠分别随机分为DM组和对照组,STZ液腹腔注射建立DM大鼠模型,喂养8周后,处死大鼠,取部分左心室组织进行免疫组化;剩余部分留做心肌组织PAI-1 mRNA检测。采用EnVision免疫组化法,CD34抗体检测心肌微血管内皮细胞特异性抗原CD34。利用医学图像分析软件计数心肌微血管数目。实时荧光定量PCR法检测各组心肌组织PAI-1 mRNA的表达。结果各年龄段大鼠,DM组心肌微血管数目显著低于同龄段对照组(P<0.01),DM组心肌组织PAI-1 mRNA的表达与同龄对照组相比则显著增多(P<0.01);老龄DM组心肌微血管数目明显低于青年DM组及青年对照组(P<0.01),老龄对照组心肌微血管数目与青年对照组无明显统计学差异(P>0.05),而老龄DM组心肌组织PAI-1 mRNA表达显著高于青年DM组及青年对照组(P<0.01);并且老龄对照组心肌PAI-1 mRNA的表达也高于青年对照组(P<0.05)。结论增龄对DM大鼠心肌微血管数目有影响,而对非DM大鼠无明显影响。增龄使大鼠心肌组织PAI-1 mRNA表达增强。各年龄段DM大鼠心肌微血管数目减少,心肌组织PAI-1 mRNA表达增强。 Objective To evaluate whether hyperglycemia and ageing influence myocardial microvessels and the expression of myocardial PAI-1 mRNA by observing changes in the number of myocardial microvessels and the expression of myocardial PAI-1 mRNA in aged and young diabetic rats. Methods Aged and young SD rats were randomized to diabetes mellitus (DM) group and control group. The DM model was established by intraperitoneal STZ injection. The rats were raised for 8 weeks and sacrificed. Part of the left ventrieular tissue was used for immunohistochemical evaluation, and the remaining part was used for detection of PAI-1 mRNA exprerssion. Myocardial microvascular endothelial specific antigen CD34 was detected by using CD34 antibody and EnVision immunohistochemistry. The number of myocardial microvessels was counted by Medical Image Analysis Software. The expression of myocardial PAI- 1 mRNA was detected by real-time fluorescence quantitative PCR. Results The number of myocardial microvessels of DM group was significantly smaller than that of the control in all age groups 8 weeks after modeling (P 〈 0.01), and the number of myocardial microvessels of the aged DM group was significantly smaller than that of the young DM group and young control group (P 〈 0.01), while there was no significant difference between the aged and young control groups (P 〉 0.05). The expression of myocardial PAI- 1 mRNA in DM rats of all age groups was significantly increased as compared with the control group at corresponding ages (P 〈 0.01). In addition, the expression of myocardial PAI-1 mRNA in the aged control rats was higher than that in the young control rats (P 〈 0.05). Conclusion Ageing has a significant influence on the number of myocardial microvessels in diabetic rats but not in non-diabetic rats. Ageing enhances the expression of myocardial AI-1 mRNA in rats. The number of myocardial microvessels is decreased and the expression of myocardial PAI-1 mRNA is enhanced in diabetic rats at all ages.
出处 《中华老年多器官疾病杂志》 2011年第4期353-356,共4页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 糖尿病 心肌 微血管数目 纤溶酶原灭活剂 年龄因素 diabetes mellitus myocardium number, microvessel plasminogen activator inhibitor age reporting
  • 相关文献

参考文献12

  • 1Can" ME. Diabetes mellitus: a hypercoagulable state[J]. J Diabetes Complications, 2001, 15(1): 44-54.
  • 2Wiman B, Coollen D. Purificial and characterization of human antiplasmin, the fastacting plasmin inhibitor in plasm[J]. Eur J Biochem, 1977, 78(1): 19-26.
  • 3Eddy AA, Fogo AB. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action[J]. J Am Soc Nephrol, 2006, 17(11): 2999-3012.
  • 4Liu RM. Oxidative stress, plasmingeon activator inhibtor 1, and lung fibrosis[J]. Antioxid Redax Signal, 2008, 10(2): 303-319.
  • 5Hoffstedt J,Persson L,Isaksson B, et al. The common-675 4G/5G polymorphism in the plasmingeon activator inhibitor-1 gene is strongly associated with obesity[J]. Diabetologia, 2002, 45(4): 584-587.
  • 6Eva A, Marcus L, Tom O, et al. uPA and PAI-1 in rectal cancer: relationship to radiotherapy and clinical outcome[J]. J Surg Res, 2009, 153(1): 46-53.
  • 7Festa A, D'Agostino RJr, Tracy RP, et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study[J]. Diabetes, 2002, 51(4): 1131-1137.
  • 8Kitagawa N,Yano Y,Gabazza EC, et al. Different metabolic correlations of thrombin activatable fibrinolysis inhibitor-1 in non-obese type 2 diabetic patients[J]. Diabetes Res Clin Pract, 2006, 73(2): 150-157.
  • 9Laima B, Kevin R, Alicia J, et al. Plasminogen activator inhibitor-1 activity in type 2 diabtetes: a different relationship with coronary heart disease and diabetic retinopathy[J]. Arterioscler Thromb Vase Biol, 2008, 28(4): 786-791.
  • 10Paueksakon P, Revelo MP, Ma I.A, et al. Microangiopathic injury and augmented PAI-1 in humain diabetic nephropathy[J]. Kidney Int, 2002, 61(6): 2142-2148.

同被引文献6

  • 1Strutz F,Zeisberg M,Renziehausen A,et al.TGF-beta 1 induces prolifera-tion in human renal fibroblasts via induction of basic fibroblast growth fac-tor(FGF-2)(J).Kidney Int,2001;59(2):579-92.
  • 2Basile DP.Transforming growth factor-beta as a target for treatment in dia-betic nephropathy(J).Am J Kidney Dis,2001;38(4):887-92.
  • 3Chainy GB,Samantaray S,Samanta L.Testosterone-induced changes in testicular antioxidant system(J).Andrologia,1997;29(6):343-9.
  • 4Lang F,Klingel K,Wagner CA,et al.Deranged transcriptional regulation of cell-volume sensitive kinase hSGK in diabetic nephropathy(J).Proc Nati Acad Sci USA,2000;97(14):8157-62.
  • 5杨丽霞,任彬,李彧,李亚东,刘铜华,牛建昭.姜黄素对TGF-β1诱导人肾小管上皮细胞增殖的影响[J].北京中医药大学学报,2008,31(10):682-684. 被引量:7
  • 6易继飞,王全胜,张丽晓,刘建国,李仁康.血竭素高氯酸盐抑制高糖/SGK_1/FN通路防治糖尿病肾病小鼠肾纤维化[J].华中科技大学学报(医学版),2010,39(1):69-72. 被引量:4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部